NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Adicet Bio Inc (NASDAQ: ACET)

 
ACET Technical Analysis
5
As on 25th Apr 2025 ACET SHARE Price closed @ 0.59 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.78 & Strong Sell for SHORT-TERM with Stoploss of 1.71 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACETSHARE Price

Open 0.61 Change Price %
High 0.62 1 Day -0.02 -3.28
Low 0.58 1 Week 0.00 0.00
Close 0.59 1 Month -0.19 -24.36
Volume 128788 1 Year -1.06 -64.24
52 Week High 3.45 | 52 Week Low 0.45
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
GNLN 0.01 -50.00%
AGMH 0.05 25.00%
OMEX 1.51 77.65%
NVDA 111.01 4.30%
WW 0.40 166.67%
TSLA 284.95 9.80%
INTC 20.05 -6.70%
OPEN 0.76 -2.56%
LMDX 0.02 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
ZWZZT 25.00 2375.25%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
WW 0.40 166.67%
WINVR 0.12 140.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
TFFP 0.06 -62.50%
ATMH 0.04 -60.00%
MILEW 0.06 -53.85%
LOTZW 0.01 -50.00%
 
 
ACET
Daily Charts
ACET
Intraday Charts
Whats New @
Bazaartrend
ACET
Free Analysis
 
ACET Important Levels Intraday
RESISTANCE0.67
RESISTANCE0.64
RESISTANCE0.63
RESISTANCE0.61
SUPPORT0.57
SUPPORT0.55
SUPPORT0.54
SUPPORT0.51
 
ACET Forecast April 2025
4th UP Forecast5.45
3rd UP Forecast3.89
2nd UP Forecast2.93
1st UP Forecast1.96
1st DOWN Forecast-0.78
2nd DOWN Forecast-1.75
3rd DOWN Forecast-2.71
4th DOWN Forecast-4.27
 
ACET Weekly Forecast
4th UP Forecast1.03
3rd UP Forecast0.89
2nd UP Forecast0.80
1st UP Forecast0.72
1st DOWN Forecast0.46
2nd DOWN Forecast0.38
3rd DOWN Forecast0.29
4th DOWN Forecast0.15
 
ACET Forecast2025
4th UP Forecast6.99
3rd UP Forecast4.94
2nd UP Forecast3.67
1st UP Forecast2.4
1st DOWN Forecast-1.22
2nd DOWN Forecast-2.49
3rd DOWN Forecast-3.76
4th DOWN Forecast-5.81
 
 
ACET Other Details
Segment EQ
Market Capital 275435872.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACET Address
ACET
 
ACET Latest News
 
Your Comments and Response on Adicet Bio Inc
 
ACET Business Profile
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase 1 clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors, including hepatocellular carcinoma, gastric cancer, and squamous cell carcinoma of the lung. The company is based in Boston, Massachusetts. Address: 500 Boylston Street, Boston, MA, United States, 02116
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service